Literature DB >> 2828214

Hepatic encephalopathy and orotic aciduria associated with hepatocellular carcinoma in a noncirrhotic liver.

L J Jeffers1, R A Dubow, L Zieve, K R Reddy, A S Livingstone, S Neimark, M Viamonte, E R Schiff.   

Abstract

A 40-yr-old man presented with encephalopathy and was found to have hepatocellular carcinoma without cirrhosis. A large vascular hepatic mass was defined by CT scan and angiography; laparoscopy with biopsy confirmed the absence of chronic liver disease. A definitive tissue diagnosis of hepatocellular carcinoma was made at laparotomy; the tumor was unresectable. Peripheral arterial and selective portal and hepatic venous ammonia levels were high, and this finding suggested that the encephalopathy was nitrogenous and hepatic in origin. The proposed mechanisms of the encephalopathy are generation of ammonia from tumor breakdown and portosystemic shunting, a result of partial tumor occlusion of the hepatic veins. An unusually high urinary excretion of orotic acid was found similar to that seen in hereditary orotic aciduria.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2828214     DOI: 10.1002/hep.1840080116

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  4 in total

1.  Mitochondrial metabolism in the noncancerous liver determine the occurrence of hepatocellular carcinoma: a prospective study.

Authors:  Atsushi Kudo; Kaoru Mogushi; Tadatoshi Takayama; Satoshi Matsumura; Daisuke Ban; Takumi Irie; Takanori Ochiai; Noriaki Nakamura; Hiroshi Tanaka; Naohiko Anzai; Michiie Sakamoto; Shinji Tanaka; Shigeki Arii
Journal:  J Gastroenterol       Date:  2013-03-30       Impact factor: 7.527

2.  Fibrolamellar hepatocellular carcinoma mimicking ornithine transcarbamylase deficiency.

Authors:  Raashda A Sulaiman; Tarekegn Geberhiwot
Journal:  JIMD Rep       Date:  2014-07-05

3.  Hyperammonemic encephalopathy in an adenocarcinoma patient managed with carglumic acid.

Authors:  J Lazier; S M Lupichuk; I Sosova; A A Khan
Journal:  Curr Oncol       Date:  2014-10       Impact factor: 3.677

4.  Efficacy of N-carbamoyl-L-glutamic acid for the treatment of inherited metabolic disorders.

Authors:  Cristel C Chapel-Crespo; George A Diaz; Kimihiko Oishi
Journal:  Expert Rev Endocrinol Metab       Date:  2016-09-28
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.